Clinical Trial Update: Study Impact on Outcome of Eltrombopag in Elderly Patients with Acute Myeloid Leukemia Receiving Induction Chemotherapy [Phase 2]

View source ↗

Summary

Clinical trial update on eltrombopag for elderly patients with acute myeloid leukemia undergoing induction chemotherapy (Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Eltrombopag (eltrombopag)

Snippet

Sponsor: French Innovative Leukemia Organisation | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING